资讯

PipelineReview.com22 小时
Elevation Oncology Presents Preclinical Proof-of-Concept Data for EO-1022 at the American ...
EO-1022 is a potentially differentiated HER3 ADC designed to address significant unmet needs across multiplesolid tumors -- ...